Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Psychedelic Drug Legislative Reform and Legalization in the US
Joshua S. Siegel
, James E. Daily
, Demetrius A. Perry
,
Ginger E. Nicol
Institute of Clinical and Translational Sciences (ICTS)
mHealth Research Core
Intellectual and Developmental Disabilities Research Center (IDDRC)
Division of Adult Acute Clinical
Division of Clinical Neuroscience and Behavioral Health Research
Research output
:
Contribution to journal
›
Review article
›
peer-review
152
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Psychedelic Drug Legislative Reform and Legalization in the US'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Legislative Reform
100%
Psychedelic Drugs
100%
Psychedelics
66%
Healthcare Professionals
33%
Criminalization
33%
Legislative Initiative
33%
Psilocybin
33%
Older Adults
16%
Should Be Given
16%
Medical Research
16%
Special Populations
16%
Pregnant Women
16%
Politicians
16%
Marijuana
16%
Health Problems
16%
Oregon
16%
3,4-methylenedioxymethamphetamine
16%
Treatment Guidance
16%
Online Treatment
16%
Liberal
16%
Adult Humans
16%
Evidence Review
16%
Billing
16%
Prescribers
16%
Treatment Model
16%
2-axis
16%
Licensure
16%
Care Planning
16%
Analytic Model
16%
Ayahuasca
16%
Regulatory Guidance
16%
Professional Policy
16%
Presidential Voting
16%
Ibogaine
16%
Licensure Requirements
16%
Medical Oversight
16%
Drug Policy Reform
16%
Right to Try
16%
State Index
16%
Ballot Measures
16%
LexisNexis
16%
Mescaline
16%
Peyote
16%
Liberal State
16%
Therapist
16%
Or Training
16%
Attorneys
16%
Marijuana Legalization
16%
Modeling Education
16%
Legislative Databases
16%
Medicine and Dentistry
Psychotomimetic
100%
Midomafetamine
50%
Cannabis
33%
Psilocybine
33%
Mescaline
33%
Health Care Personnel
33%
Healthcare Professional
33%
Health Care
16%
Medical Research
16%
Contraindication
16%
Billing
16%
Ibogaine
16%
Education
16%
Social Sciences
USA
100%
Psychotomimetic
100%
Decriminalization
33%
Medical Research
16%
Older Adults
16%
Education
16%
Special Population
16%
Oregon
16%